Cargando…
Enzyme replacement therapy in Hurler syndrome after failure of hematopoietic transplant
The most severe form of Mucopolysaccharosidosis type I (MPS-I), Hurler syndrome, presents with progressive respiratory, cardiac and musculoskeletal symptoms and cognitive deterioration. Treatment includes enzyme replacement therapy (ERT) and/or hematopoietic stem cell transplantation (HSCT). We desc...
Autores principales: | Arranz, Leonor, Aldamiz-Echevarria, Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750618/ https://www.ncbi.nlm.nih.gov/pubmed/26937401 http://dx.doi.org/10.1016/j.ymgmr.2015.04.003 |
Ejemplares similares
-
Long-term cognitive and somatic outcomes of enzyme replacement therapy in untransplanted Hurler syndrome
por: Eisengart, Julie B., et al.
Publicado: (2017) -
Clinical trial of laronidase in Hurler syndrome after hematopoietic cell transplantation
por: Polgreen, Lynda E., et al.
Publicado: (2019) -
Intrathecal enzyme replacement for Hurler syndrome: biomarker association with neurocognitive outcomes
por: Eisengart, Julie B., et al.
Publicado: (2019) -
Short-term growth hormone treatment in children with Hurler syndrome after hematopoietic cell transplantation
por: Polgreen, Lynda E., et al.
Publicado: (2009) -
Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure
por: Boelens, J J, et al.
Publicado: (2007)